Goldstream Capital Management Ltd acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 12,400 shares of the company's stock, valued at approximately $1,642,000. Astera Labs accounts for approximately 0.5% of Goldstream Capital Management Ltd's investment portfolio, making the stock its 15th largest holding.
Other large investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Astera Labs by 354.9% in the fourth quarter. Vanguard Group Inc. now owns 9,211,630 shares of the company's stock valued at $1,220,080,000 after acquiring an additional 7,186,582 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Astera Labs by 2,328.5% during the 4th quarter. Alliancebernstein L.P. now owns 3,922,278 shares of the company's stock worth $519,506,000 after purchasing an additional 3,760,765 shares during the last quarter. Jennison Associates LLC purchased a new stake in shares of Astera Labs in the fourth quarter valued at approximately $229,991,000. Norges Bank acquired a new stake in shares of Astera Labs in the fourth quarter valued at approximately $179,229,000. Finally, Massachusetts Financial Services Co. MA boosted its stake in Astera Labs by 418.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,674,000 shares of the company's stock worth $221,721,000 after buying an additional 1,351,007 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other Astera Labs news, Director Michael E. Hurlston sold 2,500 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total transaction of $230,200.00. Following the transaction, the director now owns 91,794 shares of the company's stock, valued at $8,452,391.52. This represents a 2.65 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Jitendra Mohan sold 350,680 shares of the firm's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $89.51, for a total value of $31,389,366.80. Following the sale, the chief executive officer now owns 2,353,655 shares in the company, valued at $210,675,659.05. This trade represents a 12.97 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 633,990 shares of company stock worth $54,235,012 over the last three months.
Astera Labs Trading Up 7.3 %
Shares of Astera Labs stock traded up $4.40 during trading on Thursday, reaching $64.55. The company's stock had a trading volume of 3,014,025 shares, compared to its average volume of 3,823,778. The firm has a market cap of $10.47 billion and a PE ratio of -37.31. The company has a 50-day moving average price of $67.36 and a two-hundred day moving average price of $90.97. Astera Labs, Inc. has a fifty-two week low of $36.22 and a fifty-two week high of $147.39.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. On average, analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the stock. Stifel Nicolaus dropped their price objective on shares of Astera Labs from $150.00 to $100.00 and set a "buy" rating for the company in a report on Thursday, April 17th. Northland Securities upgraded shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 price target for the company in a report on Tuesday, January 28th. Raymond James began coverage on Astera Labs in a research report on Friday, March 14th. They issued an "outperform" rating and a $82.00 price objective for the company. Needham & Company LLC restated a "buy" rating and issued a $140.00 target price on shares of Astera Labs in a research report on Tuesday, February 11th. Finally, Northland Capmk upgraded Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 28th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $109.25.
Check Out Our Latest Stock Report on ALAB
About Astera Labs
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
